Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma.
Sahebi, F
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. [electronic resource] - Bone marrow transplantation May 2006 - 825-9 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article
0268-3369
10.1038/sj.bmt.1705339 doi
Aged
Angiogenesis Inhibitors--therapeutic use
Combined Modality Therapy
Disease Progression
Female
Humans
Male
Middle Aged
Multiple Myeloma--blood supply
Neoplasm Staging
Stem Cell Transplantation--adverse effects
Survival Analysis
Survivors
Thalidomide--therapeutic use
Time Factors
Transplantation, Autologous
Treatment Outcome
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myeloma. [electronic resource] - Bone marrow transplantation May 2006 - 825-9 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article
0268-3369
10.1038/sj.bmt.1705339 doi
Aged
Angiogenesis Inhibitors--therapeutic use
Combined Modality Therapy
Disease Progression
Female
Humans
Male
Middle Aged
Multiple Myeloma--blood supply
Neoplasm Staging
Stem Cell Transplantation--adverse effects
Survival Analysis
Survivors
Thalidomide--therapeutic use
Time Factors
Transplantation, Autologous
Treatment Outcome